Roivant Sciences Ltd. ($ROIV)
Filing Information
| Accession Number | 0001635088-26-000017 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 18, 2026 |
| Document Date | Feb 13, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
600,000
Total Value
$6,068,000.00
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
President & Immunovant CEO | Common Shares | โ | Feb 13, 2026 | Exercise/Conversion | 200,000 | $3.85 | $770,000.00 | 1,854,597 | Direct | โ | View Details | |
President & Immunovant CEO | Common Shares | โ | Feb 13, 2026 | Sale | 200,000 | $26.49 | $5,298,000.00 | 1,654,597 | Direct | โ | View Details | |
President & Immunovant CEO | Stock Option (Right to Buy) | Derivative | Feb 13, 2026 | Exercise/Conversion | 200,000 | $0.00 | $0.00 | 5,044,834 | Direct | โ | View Details |